NKTR•benzinga•
Piper Sandler Initiates Coverage On Nektar Therapeutics with Overweight Rating, Announces Price Target of $7
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 4, 2024 by benzinga